Sequential ultrasound molecular imaging for noninvasive identification and assessment of non-alcoholic steatohepatitis in mouse models
Open Access
- 1 December 2023
- journal article
- research article
- Published by KEAI Publishing in Liver Research
- Vol. 7 (4) , 342-351
Abstract
Noninvasive non-alcoholic steatohepatitis (NASH) assessment is a clinical challenge to the management of non-alcoholic fatty liver disease. We aim to develop diagnostic models based on sequential ultrasound molecular imaging (USMI) for the noninvasive identification of NASH in mouse models. Animal experiments were approved by the Animal Ethics Committee of South China Agricultural University. Forty-nine C57BL/6 mice were divided into normal control, non-alcoholic fatty liver, NASH, and hepatitis groups. Sequential USMI was implemented using CD36-targeted microbubbles (MBs-CD36) and intercellular adhesion molecule-1 (ICAM-1)-targeted microbubbles (MBs-ICAM-1) to visualize hepatic steatosis and inflammation. The targeting signal of USMI was quantified as the normalized intensity difference (NID) with the destruction-replenishment method. Correlation analysis was conducted between the NID-MBs-CD36 and pathological steatosis score and between the NID-MBs-ICAM-1 and pathological inflammation score. Finally, diagnostic models combining NID-MBs-CD36 with NID-MBs-ICAM-1 were established for NASH diagnosis. MBs-CD36 and MBs-ICAM-1 were successfully prepared and used for sequential USMI in all mice. NID-MBs-CD36 values increased with the progression of steatosis, while NID-MBs-ICAM-1 values increased in parallel with the progression of inflammation. A strong positive correlation was identified between NID-MBs-CD36 and pathological steatosis grade (rs = 0.9078, P < 0.0001) and between NID-MBs-ICAM-1 and pathological inflammation grade (rs = 0.9071, P < 0.0001). Among various sequential USMI-based diagnostic models, the serial testing model showed high diagnostic performance in detecting NASH, with 95% sensitivity, 97% specificity, 95% positive predictive values, 97% negative predictive values, and 96% accuracy. Sequential USMI using MBs-CD36 and MBs-ICAM-1 allows noninvasive grading of hepatic steatosis and inflammation. Sequential USMI-based diagnostic models hold great potential in the noninvasive identification of NASH.Keywords
Funding Information
- National Natural Science Foundation of China (82272021)
- Natural Science Foundation of Guangdong Province (2021A1515010635)
- Guangzhou Municipal Science and Technology Project (2023A03J0216)
- South China Agricultural University
This publication has 31 references indexed in Scilit:
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology, 2016
- Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubbleBiomaterials, 2015
- Triple Bioluminescence Imaging for In Vivo Monitoring of Cellular ProcessesMolecular Therapy Nucleic Acids, 2013
- Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver diseaseJournal of Hepatology, 2012
- Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkersJournal of Hepatology, 2012
- Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis CGut, 2011
- Role of Scavenger Receptor A and CD36 in Diet-Induced Nonalcoholic Steatohepatitis in Hyperlipidemic MiceGastroenterology, 2010
- Pathology of nonalcoholic fatty liver diseaseNature Reviews Gastroenterology & Hepatology, 2010
- Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver diseaseGut, 2009
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005